SCHEMBL25366361

SCHEMBL25366361

CC(C)(C)C[C@@](N)(O)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 2/20 0.45
KCNN4 O15554 1/20 0.42
MAPT P10636 1/20 0.42
KMT2A Q03164 1/20 0.42
CYP2C19 P33261 2/20 0.41
HIF1A Q16665 1/20 0.41
ALDH1A1 P00352 3/20 0.40
ALOX15 P16050 1/20 0.40
SLC6A2 P23975 1/20 0.40
POLB P06746 1/20 0.39
ESR1 P03372 2/20 0.39
ESR2 Q92731 2/20 0.39
CYP1A2 P05177 2/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2D6 P10635 1/20 0.38
MAPK1 P28482 1/20 0.38
SHBG P04278 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5085651 0.77 KCNN4 (0.46) TAAR1KCNN4MAPTKMT2ACYP2C19
SCHEMBL42067 0.77 KCNN4 (0.46) TAAR1KCNN4MAPTKMT2ACYP2C19
SCHEMBL28065526 0.77 KCNN4 (0.46) TAAR1KCNN4MAPTKMT2ACYP2C19
SCHEMBL27367620 0.77 CYP2C19 (0.46) TAAR1MAPTKMT2ACYP2C19HIF1A
SCHEMBL31590503 0.77 SMN1; SMN2 (0.48) TAAR1KMT2ACYP2C19HIF1AALDH1A1
Ammonia Solution, Strong SCHEMBL28061497 0.76 KCNN4 (0.44) TAAR1KCNN4MAPTKMT2ACYP2C19
SCHEMBL8370180 0.76 KCNN4 (0.44) TAAR1KCNN4MAPTKMT2ACYP2C19
SCHEMBL2065498 0.75 TAAR1 (0.52) TAAR1MAPTKMT2ACYP2C19HIF1A
SCHEMBL2790358 0.75 TAAR1 (0.50) TAAR1KCNN4CYP2C19HIF1AALDH1A1
Hydrochloric Acid SCHEMBL326016 0.74 SMN1; SMN2 (0.46) TAAR1KCNN4KMT2ACYP2C19CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240400517-A1 CHIRAL BIMETALLIC COOPERATIVE CATALYSIS SYSTEM AND USE THEREOF IN ASYMMETRIC SYNTHESIS OF BEDAQUILINE SHANGHAI JIAO TONG UNIVERSITY (CN) 2024-12-05 US disclosed
CN-116603570-A Double-chiral metal synergistic catalytic system and application thereof in asymmetric synthesis of bedaquiline 上海交通大学 2023-08-18 CN disclosed
WO-2023151700-A1 DOUBLE-CHIRAL METAL COOPERATIVE CATALYSIS SYSTEM AND USE THEREOF IN ASYMMETRIC SYNTHESIS OF BEDAQUILINE 上海交通大学 2023-08-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240400517-A1 CHIRAL BIMETALLIC COOPERATIVE CATALYSIS SYSTEM AND USE THEREOF IN ASYMMETRIC SYNTHESIS OF BEDAQUILINE MAP2K4, MAP2K7, MAP2K5 TAAR1 2531/4885KCNN4 183/4885MAPT 2386/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.